Common variable immunodeficiency: Etiological and treatment issues

International Archives of Allergy and Immunology

Volumn 150, Issue 4, 2009, Pages 311-324

  Deane, Sean ^a   Selmi, Carlo ^a   Naguwa, Stanley M ^a   Teuber, Suzanne S ^a   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmunity; B cells; Immunodeficiency; Recurrent infections

Indexed keywords

ANTIBIOTIC AGENT; CARIMUNE; HUMAN IMMUNOGLOBULIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; BLOOD DISEASE; CANCER SCREENING; CLINICAL FEATURE; COMMON VARIABLE IMMUNODEFICIENCY; DELAYED DIAGNOSIS; FLOW CYTOMETRY; GASTROINTESTINAL DISEASE; GASTROINTESTINAL ENDOSCOPY; HUMAN; IMMUNE FUNCTION TEST; IMMUNOGLOBULIN G DEFICIENCY; IMMUNOTHERAPY; LUNG INFECTION; MONOGENIC DISORDER; MORBIDITY; NEOPLASM; PATHOGENESIS; PATIENT MONITORING; PERSISTENT INFECTION; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RECURRENT INFECTION; RESPIRATORY TRACT EXAMINATION; REVIEW; SCREENING TEST; SUBSTITUTION THERAPY;

ANIMALS; ANTI-BACTERIAL AGENTS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; COMMON VARIABLE IMMUNODEFICIENCY; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFECTION; LYMPHOCYTE ACTIVATION; MONITORING, PHYSIOLOGIC; NEOPLASMS; T-LYMPHOCYTES;

EID: 67649442744     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000226232     Document Type: Review

References (189)

1. Cooper MD, Faulk WP, Fudenberg HH, Good RA, Hitzig W, Kunkel H, Rosen FS, Seligmann M, Soothill J, Wedgwood RJ: Classification of primary immunodeficiencies. N Engl J Med 1973; 288: 966-967.
2. Spickett GP, Farrant J, North ME, Zhang JG, Morgan L, Webster AD: Common variable immunodeficiency: how many diseases? Immunol Today 1997; 18: 325-328.
3. Janeway CA, Apt L, Gitlin D: Agammaglobulinemia. Trans Assoc Am Physicians 1953; 66: 200-202.
4. Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological Societies. Clin Exp Immunol 1999; 118(suppl 1):1-28.
5. Boncristiano M, Majolini MB, D'Elios MM, Pacini S, Valensin S, Ulivieri C, Amedei A, Falini B, Del Prete G, Telford JL, Baldari CT: Defective recruitment and activation of ZAP-70 in common variable immunodeficiency patients with T cell defects. Eur J Immunol 2000; 30: 2632-2638.
6. Buckley RH: Pulmonary complications of primary immunodeficiencies. Paediatr Respir Rev 2004; 5(suppl A):S225-S233.
7. Grimbacher B, Hutloff A, Schlesier M, Glocker E, Warnatz K, Drager R, Eibel H, Fischer B, Schaffer AA, Mages HW, Kroczek RA, Peter HH: Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 2003; 4: 261-268.
8. Jaffe JS, Eisenstein E, Sneller MC, Strober W: T-cell abnormalities in common variable immunodeficiency. Pediatr Res 1993; 33: S24-S27; discussion S27-S28.
9. Morimoto Y, Routes JM: Immunodeficiency overview. Prim Care 2008; 35: 159-173, viii.
10. Salzer U, Grimbacher B: Monogenetic defects in common variable immunodeficiency: what can we learn about terminal B cell differentiation? Curr Opin Rheumatol 2006; 18: 377-382.
11. Sneller MC, Strober W, Eisenstein E, Jaffe JS, Cunningham-Rundles C: NIH conference: new insights into common variable immunodeficiency. Ann Intern Med 1993; 118: 720-730.
12. Di Renzo M, Pasqui AL, Auteri A: Common variable immunodeficiency: a review. Clin Exp Med 2004; 3: 211-217.
13. Schaffer AA, Salzer U, Hammarstrom L, Grimbacher B: Deconstructing common variable immunodeficiency by genetic analysis. Curr Opin Genet Dev 2007; 17: 201-212. (Pubitemid 46850798)
14. Bonilla FA, Bernstein IL, Khan DA, Ballas ZK, Chinen J, Frank MM, Kobrynski LJ, Levinson AI, Mazer B, Nelson RP Jr., Orange JS, Routes JM, Shearer WT, Sorensen RU: Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol 2005; 94:S1-S63.
15. Castigli E, Geha RS: TACI, isotype switching, CVID and IgAD. Immunol Res 2007; 38: 102-111.
16. Cunningham-Rundles C: Clinical and immunologic studies of common variable immunodeficiency. Curr Opin Pediatr 1994; 6: 676-681.
17. Hammarstrom L, Vorechovsky I, Webster D: Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 2000; 120: 225-231.
18. Centers for Disease Control and Prevention: HIV prevalence estimates: United States, 2006. MMWR Morb Mortal Wkly Rep 2008; 57: 1073-1076.
19. Cunningham-Rundles C, Bodian C: Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999; 92: 34-48.
20. Mehra A, Sidi P, Doucette J, Estrella L, Rouvelas H, Cunningham-Rundles C: Subspecialty evaluation of chronically ill hospitalized patients with suspected immune defects. Ann Allergy Asthma Immunol 2007; 99: 143-150.
21. Yarmohammadi H, Estrella L, Doucette J, Cunningham-Rundles C: Recognizing primary immune deficiency in clinical practice. Clin Vaccine Immunol 2006; 13: 329-332.
22. Eades-Perner AM, Gathmann B, Knerr V, Guzman D, Veit D, Kindle G, Grimbacher B: The European internet-based patient and research database for primary immunodeficiencies: results 2004-2006. Clin Exp Immunol 2007; 147: 306-312.
23. De Santis W, Esposito A, Conti V, Fantauzzi A, Guerra A, Mezzaroma I, Aiuti F: Health care and infective aspects in patients affected by common variable immunodeficiency assisted in the Lazio Regional Authority Reference Centre for Primary Immunodeficiencies (in Italian). Infez Med 2006; 14: 13-23.
24. Cunningham-Rundles C, Sidi P, Estrella L, Doucette J: Identifying undiagnosed primary immunodeficiency diseases in minority subjects by using computer sorting of diagnosis codes. J Allergy Clin Immunol 2004; 113: 747-755.
25. Agarwal S, Cunningham-Rundles C: Assessment and clinical interpretation of reduced IgG values. Ann Allergy Asthma Immunol 2007; 99: 281-283.
26. Mrusek S, Marx A, Kummerle-Deschner J, Tzaribachev N, Enders A, Riede UN, Warnatz K, Dannecker GE, Ehl S: Development of granulomatous common variable immunodeficiency subsequent to infection with Toxoplasma gondii . Clin Exp Immunol 2004; 137: 578-583.
27. Buckley RH: Primary immunodeficiency or not? Making the correct diagnosis. J Allergy Clin Immunol 2006; 117: 756-758.
28. Conley ME, Notarangelo LD, Etzioni A: Diagnostic criteria for primary immunodeficiencies: representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 1999; 93: 190-197.
29. Buckley RH: Primary Immunodeficiency Diseases; A. W. Burks, B. W., R. S., et al. ATS/ AAAAI 2008 Pulmonary And Allergy Fellows Symposia. Toronto, 2008, 189-240.
30. Eastwood D, Gilmour KC, Nistala K, Mea ney C, Chapel H, Sherrell Z, Webster AD, Davies EG, Jones A, Gaspar HB: Prevalence of SAP gene defects in male patients diagnosed with common variable immunodeficiency. Clin Exp Immunol 2004; 137: 584-588.
31. Goldacker S, Warnatz K: Tackling the heterogeneity of CVID. Curr Opin Allergy Clin Immunol 2005; 5: 504-509.
32. Salzer U, Hagena T, Webster DB, Grimbacher B: Sequence analysis of BIRC4/XIAP in male patients with common variable immunodeficiency. Int Arch Allergy Immunol 2008; 147: 147-151.
33. Weston SA, Prasad ML, Mullighan CG, Chapel H, Benson EM: Assessment of male CVID patients for mutations in the Btk gene: how many have been misdiagnosed? Clin Exp Immunol 2001; 124: 465-469.
34. Hermaszewski RA, Webster AD: Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med 1993; 86: 31-42.
35. Quinti I, Soresina A, Spadaro G, Martino S, Donnanno S, Agostini C, Claudio P, Franco D, Maria Pesce A, Borghese F, Guerra A, Rondelli R, Plebani A: Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol 2007; 27: 308-316.
36. Van der Hilst JC, Smits BW, van der Meer JW: Hypogammaglobulinaemia: cumulative experience in 49 patients in a tertiary care institution. Neth J Med 2002; 60: 140-147.
37. Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A, Hammarstrom L, Nonoyama S, Ochs HD, Puck JM, Roifman C, Seger R, Wedgwood J: Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol 2007; 120: 776-794.
38. Busse PJ, Farzan S, Cunningham-Rundles C: Pulmonary complications of common variable immunodeficiency. Ann Allergy Asthma Immunol 2007; 98: 1-8; quiz 8-11, 43.
39. Curtin JJ, Webster AD, Farrant J, Katz D: Bronchiectasis in hypogammaglobulinaemia: a computed tomography assessment. Clin Radiol 1991; 44: 82-84.
40. Hermans PE, Diaz-Buxo JA, Stobo JD: Idiopathic late-onset immunoglobulin deficiency: clinical observations in 50 patients. Am J Med 1976; 61: 221-237.
41. Kainulainen L, Varpula M, Liippo K, Svedstrom E, Nikoskelainen J, Ruuskanen O: Pulmonary abnormalities in patients with primary hypogammaglobulinemia. J Allergy Clin Immunol 1999; 104: 1031-1036.
42. Litzman J, Freiberger T, Grimbacher B, Gathmann B, Salzer U, Pavlik T, Vlcek J, Postranecka V, Travnickova Z, Thon V: Mannose-binding lectin gene polymorphic variants predispose to the development of bronchopulmonary complications but have no influence on other clinical and laboratory symptoms or signs of common variable immunodeficiency. Clin Exp Immunol 2008; 153: 324-330.
43. Martinez Garcia MA, de Rojas MD, Nauffal Manzur MD, Munoz Pamplona MP, Compte Torrero L, Macian V, Perpina Tordera M: Respiratory disorders in common variable immunodeficiency. Respir Med 2001; 95: 191-195.
44. Obregon RG, Lynch DA, Kaske T, Newell JD Jr., Kirkpatrick CH: Radiologic findings of adult primary immunodeficiency disorders: contribution of CT. Chest 1994; 106: 490-495.
45. Ogershok PR, Hogan MB, Welch JE, Corder WT, Wilson NW: Spectrum of illness in pediatric common variable immunodeficiency. Ann Allergy Asthma Immunol 2006; 97: 653-656.
46. Quartier P, Debre M, De Blic J, de Sauverzac R, Sayegh N, Jabado N, Haddad E, Blanche S, Casanova JL, Smith CI, Le Deist F, de Saint Basile G, Fischer A: Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients. J Pediatr 1999; 134: 589-596.
47. Sweinberg SK, Wodell RA, Grodofsky MP, Greene JM, Conley ME: Retrospective analysis of the incidence of pulmonary disease in hypogammaglobulinemia. J Allergy Clin Immunol 1991; 88: 96-104.
48. Tanaka N, Kim JS, Bates CA, Brown KK, Cool CD, Newell JD, Lynch DA: Lung diseases in patients with common variable immunodeficiency: chest radiographic, and computed tomographic findings. J Comput Assist Tomogr 2006; 30: 828-838.
49. Bates CA, Ellison MC, Lynch DA, Cool CD, Brown KK, Routes JM: Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency. J Allergy Clin Immunol 2004; 114: 415-421.
50. Dibbern DA Jr., Claman HN, Dreskin SC: Dyspnea and pulmonary infiltrates in a 53- year-old woman with common variable immunodeficiency. Ann Allergy Asthma Immunol 2001; 87: 18-21.
51. Morimoto Y, Routes JM: Granulomatous disease in common variable immunodeficiency. Curr Allergy Asthma Rep 2005; 5: 370-375.
52. Daniels JA, Lederman HM, Maitra A, Montgomery EA: Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. Am J Surg Pathol 2007; 31: 1800- 1812.
53. Stack E, Washington K, Avant GR, Eisen GM: Cytomegalovirus enteritis in common variable immunodeficiency. South Med J 2004; 97: 96-101.
54. Tarr PE, Sneller MC, Mechanic LJ, Economides A, Eger CM, Strober W, Cunningham-Rundles C, Lucey DR: Infections in patients with immunodeficiency with thymoma (Good syndrome): report of 5 cases and review of the literature. Medicine (Baltimore) 2001; 80: 123-133.
55. Bjorkander J, Cunningham-Rundles C, Lundin P, Olsson R, Soderstrom R, Hanson LA: Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency. Am J Med 1988; 84: 107-111.
56. Fukushima K, Ueno Y, Kanegane H, Yamagiwa Y, Inoue J, Kido O, Nagasaki F, Kogure T, Kakazu E, Nakagome Y, Matsuda Y, Obara N, Kimura O, Shimosegawa T: A case of severe recurrent hepatitis with common variable immunodeficiency. Hepatol Res 2008; 38: 415-420.
57. Razvi S, Schneider L, Jonas MM, Cunningham-Rundles C: Outcome of intravenous immunoglobulin-transmitted hepatitis C virus infection in primary immunodeficiency. Clin Immunol 2001; 101: 284-288.
58. Thatayatikom A, Thatayatikom S, White AJ: Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature. Ann Allergy Asthma Immunol 2005; 95: 293-300.
59. Brandt D, Gershwin ME: Common variable immune deficiency and autoimmunity. Autoimmun Rev 2006; 5: 465-470.
60. Iyengar SR, Blackburn BG, Lewis DB: Severe hypogammaglobulinemia and absent B cells in an adult patient: a case report. J Allergy Clin Immunol 2007;119(suppl 1):S256.
61. Jerschow E, De Vos GS, Hudes G, Rubinstein A, Lipsitz EC, Rosenstreich D: A case of common variable immunodeficiency syndrome associated with Takayasu arteritis. Ann Allergy Asthma Immunol 2007; 98: 196-199.
62. Cunningham-Rundles C: Hematologic complications of primary immune deficiencies. Blood Rev 2002; 16: 61-64.
63. Chen X, Jensen PE: MHC class II antigen presentation and immunological abnormalities due to deficiency of MHC class II and its associated genes. Exp Mol Pathol 2008; 85: 40-44.
64. Ehlers M, Ravetch JV: Opposing effects of Toll-like receptor stimulation induce autoimmunity or tolerance. Trends Immunol 2007; 28: 74-79.
65. Harrison LC, Honeyman MC, Morahan G, Wentworth JM, Elkassaby S, Colman PG, Fourlanos S: Type 1 diabetes: lessons for other autoimmune diseases? J Autoimmun 2008; 31: 306-310.
66. Hogan TV, Ang DK, Gleeson PA, van Driel IR: Extrathymic mechanisms of T cell tolerance: Lessons from autoimmune gastritis. J Autoimmun 2008; 31: 268-273.
67. Jordan MA, Baxter AG: The genetics of immunoregulatory T cells. J Autoimmun 2008; 31: 237-244.
68. Lan RY, Mackay IR, Gershwin ME: Regulatory T cells in the prevention of mucosal inflammatory diseases: patrolling the border. J Autoimmun 2007; 29: 272-280.
69. Morahan G, Peeva V, Mehta M, Williams R: Systems genetics can provide new insights in to immune regulation and autoimmunity. J Autoimmun 2008; 31: 233-236.
70. Ryan KR, Patel SD, Stephens LA, Anderton SM: Death, adaptation and regulation: the three pillars of immune tolerance restrict the risk of autoimmune disease caused by molecular mimicry. J Autoimmun 2007; 29: 262-271.
71. Pai S, Thomas R: Immune deficiency or hyperactivity- Nf-kappab illuminates autoimmunity. J Autoimmun 2008; 31: 245-251.
72. Poletaev AB, Stepanyuk VL, Gershwin ME: Integrating immunity: the immunculus and self-reactivity. J Autoimmun 2008; 30: 68-73.
73. Ng YS, Wardemann H, Chelnis J, Cunningham-Rundles C, Meffre E: Bruton's tyrosine kinase is essential for human B cell tolerance. J Exp Med 2004; 200: 927-934.
74. Michel M, Chanet V, Galicier L, Ruivard M, Levy Y, Hermine O, Oksenhendler E, Schaeffer A, Bierling P, Godeau B: Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature. Medicine (Baltimore) 2004; 83: 254-263.
75. Arnold DF, Wiggins J, Cunningham-Rundles C, Misbah SA, Chapel HM: Granulomatous disease: distinguishing primary antibody disease from sarcoidosis. Clin Immunol 2008; 128: 18-22.
76. Sutor G, Fabel H: Sarcoidosis and common variable immunodeficiency: a case of a malignant course of sarcoidosis in conjunction with severe impairment of the cellular and humoral immune system. Respiration 2000; 67: 204-208.
77. Wang J, Cunningham-Rundles C: Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). J Autoimmun 2005; 25: 57-62.
78. Wang J, Rodriguez-Davalos M, Levi G, Sauter B, Gondolesi GE, Cunningham-Rundles C: Common variable immunodeficiency presenting with a large abdominal mass. J Allergy Clin Immunol 2005; 115: 1318-1320.
79. Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, Vlkova M, Hernandez M, Detkova D, Bos PR, Poerksen G, von Bernuth H, Baumann U, Goldacker S, Gutenberger S, Schlesier M, Bergeron-van der Cruyssen F, Le Garff M, Debre P, Jacobs R, Jones J, Bateman E, Litzman J, van Hagen PM, Plebani A, Schmidt RE, Thon V, Quinti I, Espanol T, Webster AD, Chapel H, Vihinen M, Oksenhendler E, Peter HH, Warnatz K: The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 2008; 111: 77-85.
80. Wheat WH, Cool CD, Morimoto Y, Rai PR, Kirkpatrick CH, Lindenbaum BA, Bates CA, Ellison MC, Serls AE, Brown KK, Routes JM: Possible role of human herpesvirus 8 in the lymphoproliferative disorders in common variable immunodeficiency. J Exp Med 2005; 202: 479-484.
81. Cunningham-Rundles C, Routes JM, Hostoffer R, Sullivan KE: Uncommon conundrum in common variable immunodeficiency. Clin Immunol 2005; 116: 208-210.
82. Park MA, Li JT, Hagan JB, Maddox DE, Abraham RS: Common variable immunodeficiency: a new look at an old disease. Lancet 2008; 372: 489-502.
83. Cunningham-Rundles C, Cooper DL, Duffy TP, Strauchen J: Lymphomas of mucosal-associated lymphoid tissue in common variable immunodeficiency. Am J Hematol 2002; 69: 171-178.
84. Cunningham-Rundles C, Siegal FP, Cunningham-Rundles S, Lieberman P: Incidence of cancer in 98 patients with common varied immunodeficiency. J Clin Immunol 1987; 7: 294-299.
85. Kinlen LJ, Webster AD, Bird AG, Haile R, Peto J, Soothill JF, Thompson RA: Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet 1985; 1: 263-266.
86. Mellemkjaer L, Hammarstrom L, Andersen V, Yuen J, Heilmann C, Barington T, Bjorkander J, Olsen JH: Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study. Clin Exp Immunol 2002; 130: 495-500.
87. Zenone T, Souquet PJ, Cunningham-Rundles C, Bernard JP: Hodgkin's disease associated with IgA and IgG subclass deficiency. J Intern Med 1996; 240: 99-102.
88. Agarwal S, Cunningham-Rundles C: Thymoma and immunodeficiency (Good syndrome): a report of 2 unusual cases and review of the literature. Ann Allergy Asthma Immunol 2007; 98: 185-190.
89. Di Renzo M, Pasqui AL, Bruni F, Voltolini L, Gotti G, Auteri A: Hypogammaglobulinemia and thymoma (Good's syndrome): a case report and a literature review (in Italian). Ann Ital Med Int 2005; 20: 58-61.
90. Di Renzo M, Pasqui AL, Voltolini L, Gotti G, Pompella G, Auteri A: Myelodysplasia and Good syndrome: a case report. Clin Exp Med 2008; 8: 171-173.
91. Hon C, Chui WH, Cheng LC, Shek TW, Jones BM, Au WY: Thymoma associated with keratoconjunctivitis, lichen planus, hypogammaglobinemia, and absent circulating B cells. J Clin Oncol 2006; 24: 2960-2961.
92. Piqueras B, Lavenu-Bombled C, Galicier L, Bergeron-van der Cruyssen F, Mouthon L, Chevret S, Debre P, Schmitt C, Oksenhendler E: Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol 2003; 23: 385-400.
93. Warnatz K, Denz A, Drager R, Braun M, Groth C, Wolff-Vorbeck G, Eibel H, Schlesier M, Peter HH: Severe deficiency of switched memory B cells (CD27(+)IgM (-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 2002; 99: 1544-1551.
94. Berglund LJ, Wong SW, Fulcher DA: B-cell maturation defects in common variable immunodeficiency and association with clinical features. Pathology 2008; 40: 288-294.
95. Bulley SR, Zhang J, Kwong S, Roifman C: Newly diagnosed X-linked agammaglobulinemia (XLA), bruton's tyrosine kinase (Btk) mutation, in a 39 year-old male. J Allergy Clin Immunol 2002; 109:S188.
96. Hashimoto S, Miyawaki T, Futatani T, Kanegane H, Usui K, Nukiwa T, Namiuchi S, Matsushita M, Yamadori T, Suemura M, Kishimoto T, Tsukada S: Atypical X-linked agammaglobulinemia diagnosed in three adults. Intern Med 1999; 38: 722-725.
97. Kanegane H, Futatani T, Wang Y, Nomura K, Shinozaki K, Matsukura H, Kubota T, Tsukada S, Miyawaki T: Clinical and mutational characteristics of X-linked agammaglobulinemia and its carrier identified by flow cytometric assessment combined with genetic analysis. J Allergy Clin Immunol 2001; 108: 1012-1020.
98. Kanegane H, Tsukada S, Iwata T, Futatani T, Nomura K, Yamamoto J, Yoshida T, Agematsu K, Komiyama A, Miyawaki T: Detection of Bruton's tyrosine kinase mutations in hypogammaglobulinaemic males registered as common variable immunodeficiency (CVID) in the Japanese Immunodeficiency Registry. Clin Exp Immunol 2000; 120: 512-517.
99. Kornfeld SJ, Haire RN, Strong SJ, Tang H, Sung SS, Fu SM, Litman GW: A novel mutation (Cys145 ] Stop) in Bruton's tyrosine kinase is associated with newly diagnosed Xlinked agammaglobulinemia in a 51-year-old male. Mol Med 1996; 2: 619-623.
100. Lee WI, Huang JL, Kuo ML, Lin SJ, Chen LC, Chen MT, Jaing TH: Analysis of genetic defects in patients with the common variable immunodeficiency phenotype in a single Taiwanese tertiary care hospital. Ann Allergy Asthma Immunol 2007; 99: 433-442.
101. Lee WI, Torgerson TR, Schumacher MJ, Yel L, Zhu Q, Ochs HD: Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood 2005; 105: 1881-1890.
102. Lin MT, Chien YH, Shyur SD, Huang LH, Chiang YC, Wen DC, Liang PH, Yang HC: De novo mutation in the BTK gene of atypical X-linked agammaglobulinemia in a patient with recurrent pyoderma. Ann Allergy Asthma Immunol 2006; 96: 744-748.
103. Mitsui T, Tsukamoto N, Kanegane H, Agematsu K, Sekigami T, Irisawa H, Saitoh T, Uchiumi H, Handa H, Matsushima T, Karasawa M, Murakami H, Miyawaki T, Nojima Y: X-linked agammaglobulinemia diagnosed in adulthood: a case report. Int J Hematol 2006; 84: 154-157.
104. Noordzij JG, de Bruin-Versteeg S, Hartwig NG, Weemaes CM, Gerritsen EJ, Bernatowska E, van Lierde S, de Groot R, van Dongen JJ: XLA patients with BTK splicesite mutations produce low levels of wildtype BTK transcripts. J Clin Immunol 2002; 22: 306-318.
105. Sigmon JR, Kasasbeh E, Krishnaswamy G: X-linked agammaglobulinemia diagnosed late in life: case report and review of the literature. Clin Mol Allergy 2008; 6: 5.
106. Stewart DM, Tian L, Nelson DL: A case of X-linked agammaglobulinemia diagnosed in adulthood. Clin Immunol 2001; 99: 94-99.
107. Usui K, Sasahara Y, Tazawa R, Hagiwara K, Tsukada S, Miyawaki T, Tsuchiya S, Nukiwa T: Recurrent pneumonia with mild hypogammaglobulinemia diagnosed as Xlinked agammaglobulinemia in adults. Respir Res 2001; 2: 188-192.
108. Aghamohammadi A, Kanegane H, Moein M, Farhoudi A, Pourpak Z, Movahedi M, Gharagozlou M, Zargar AA, Miyawaki T: Identification of an SH2D1A mutation in a hypogammaglobulinemic male patient with a diagnosis of common variable immunodeficiency. Int J Hematol 2003; 78: 45-47.
109. Morra M, Silander O, Calpe S, Choi M, Oettgen H, Myers L, Etzioni A, Buckley R, Terhorst C: Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome. Blood 2001; 98: 1321-1325.
110. Nistala K, Gilmour KC, Cranston T, Davies EG, Goldblatt D, Gaspar HB, Jones AM: Xlinked lymphoproliferative disease: three atypical cases. Clin Exp Immunol 2001; 126: 126-130.
111. Soresina A, Lougaris V, Giliani S, Cardinale F, Armenio L, Cattalini M, Notarangelo LD, Plebani A: Mutations of the X-linked lymphoproliferative disease gene SH2D1A mimicking common variable immunodeficiency. Eur J Pediatr 2002; 161: 656-659.
112. Bacchelli C, Buckridge S, Thrasher AJ, Gaspar HB: Translational mini-review series on immunodeficiency: molecular defects in common variable immunodeficiency. Clin Exp Immunol 2007; 149: 401-409.
113. Salzer U, Grimbacher B: Common variable immunodeficiency: the power of co-stimulation. Semin Immunol 2006; 18: 337-346.
114. Fischer MB, Hauber I, Vogel E, Wolf HM, Mannhalter JW, Eibl MM: Defective interleukin-2 and interferon-gamma gene expression in response to antigen in a subgroup of patients with common variable immunodeficiency. J Allergy Clin Immunol 1993; 92: 340-352.
115. Holm AM, Sivertsen EA, Tunheim SH, Haug T, Bjerkeli V, Yndestad A, Aukrust P, Froland SS: Gene expression analysis of peripheral T cells in a subgroup of common variable immunodeficiency shows predominance of CCR7(-) effector-memory T cells. Clin Exp Immunol 2004; 138: 278-289.
116. North ME, Webster AD, Farrant J: Defects in proliferative responses of T cells from patients with common variable immunodeficiency on direct activation of protein kinase C. Clin Exp Immunol 1991; 85: 198-201.
117. Hutloff A, Dittrich AM, Beier KC, Eljaschewitsch B, Kraft R, Anagnostopoulos I, Kroczek RA: ICOS is an inducible T-cell costimulator structurally and functionally related to CD28. Nature 1999; 397: 263-266.
118. Carreno BM, Collins M: The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 2002; 20: 29-53.
119. Ohm-Laursen L, Schjebel L, Jacobsen K, Permin H, Svejgaard A, Barington T: Normal ICOS, ICOSL and AID alleles in Danish patients with common variable immunodeficiency. Scand J Immunol 2005; 61: 566-574.
120. Salzer U, Maul-Pavicic A, Cunningham-Rundles C, Urschel S, Belohradsky BH, Litzman J, Holm A, Franco JL, Plebani A, Hammarstrom L, Skrabl A, Schwinger W, Grimbacher B: ICOS deficiency in patients with common variable immunodeficiency. Clin Immunol 2004; 113: 234-240.
121. Warnatz K, Bossaller L, Salzer U, Skrabl-Baumgartner A, Schwinger W, van der Burg M, van Dongen JJ, Orlowska-Volk M, Knoth R, Durandy A, Draeger R, Schlesier M, Peter HH, Grimbacher B: Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency. Blood 2006; 107: 3045-3052.
122. Kanegane H, Agematsu K, Futatani T, Sira MM, Suga K, Sekiguchi T, van Zelm MC, Miyawaki T: Novel mutations in a Japanese patient with CD19 deficiency. Genes Immun 2007; 8: 663-670.
123. van Zelm MC, Reisli I, van der Burg M, Castano D, van Noesel CJ, van Tol MJ, Woellner C, Grimbacher B, Patino PJ, van Dongen JJ, Franco JL: An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med 2006; 354: 1901-1912.
124. Fearon DT, Carroll MC: Regulation of B lymphocyte responses to foreign and selfantigens by the CD19/CD21 complex. Annu Rev Immunol 2000; 18: 393-422.
125. Carter RH, Fearon DT: CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 1992; 256: 105-107.
126. Castigli E, Wilson S, Garibyan L, Rachid R, Bonilla F, Schneider L, Morra M, Curran J, Geha R: Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet 2007; 39: 430-431.
127. Castigli E, Wilson SA, Garibyan L, Rachid R, Bonilla F, Schneider L, Geha RS: TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 2005; 37: 829-834.
128. Salzer U, Bacchelli C, Buckridge S, Pan- Hammarstrom Q, Jennings S, Lougaris V, Bergbreiter A, Hagena T, Birmelin J, Plebani A, Webster AD, Peter HH, Suez D, Chapel H, McLean-Tooke A, Spickett GP, Anover-Sombke S, Ochs HD, Urschel S, Belohradsky BH, Ugrinovic S, Kumararatne DS, Lawrence TC, Holm AM, Franco JL, Schulze I, Schneider P, Gertz EM, Schaffer AA, Hammarstrom L, Thrasher AJ, Gaspar HB, Grimbacher B: Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood 2009; 113: 1967-1976.
129. Salzer U, Chapel HM, Webster AD, Pan- Hammarstrom Q, Schmitt-Graeff A, Schlesier M, Peter HH, Rockstroh JK, Schneider P, Schaffer AA, Hammarstrom L, Grimbacher B: Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 2005; 37: 820-828.
130. Zhang L, Radigan L, Salzer U, Behrens TW, Grimbacher B, Diaz G, Bussel J, Cunningham-Rundles C: Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes. J Allergy Clin Immunol 2007; 120: 1178-1185.
131. Pan-Hammarstrom Q, Salzer U, Du L, Bjorkander J, Cunningham-Rundles C, Nelson DL, Bacchelli C, Gaspar HB, Offer S, Behrens TW, Grimbacher B, Hammarstrom L: Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet 2007; 39: 429-430.
132. Rachid R, Castigli E, Geha RS, Bonilla FA: TACI mutation in common variable immunodeficiency and IgA deficiency. Curr Allergy Asthma Rep 2006; 6: 357-362.
133. Jin R, Kaneko H, Suzuki H, Arai T, Teramoto T, Fukao T, Kondo N: Age-related changes in BAFF and APRIL profiles and upregulation of BAFF and APRIL expression in patients with primary antibody deficiency. Int J Mol Med 2008; 21: 233-238.
134. Mackay F, Schneider P, Rennert P, Browning J: BAFF and APRIL: a tutorial on B cell survival. Annu Rev Immunol 2003; 21: 231-264. (Pubitemid 37174532)
135. Sakurai D, Hase H, Kanno Y, Kojima H, Okumura K, Kobata T: TACI regulates IgA production by APRIL in collaboration with HSPG. Blood 2007; 109: 2961-2967.
136. Mackay F, Schneider P: TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties. Cytokine Growth Factor Rev 2008; 19: 263-276.
137. Salzer U, Grimbacher B: TACItly changing tunes: farewell to a yin and yang of BAFF receptor and TACI in humoral immunity? New genetic defects in common variable immunodeficiency. Curr Opin Allergy Clin Immunol 2005; 5: 496-503.
138. Salzer U, Jennings S, Grimbacher B: To switch or not to switch - the opposing roles of TACI in terminal B cell differentiation. Eur J Immunol 2007; 37: 17-20.
139. Grimbacher B, Salzer U, Franco JL, Warnatz K: The genetics of hypogammaglobulinemia. Inmunologia 2005; 24: 384-386.
140. Losi CG, Silini A, Fiorini C, Soresina A, Meini A, Ferrari S, Notarangelo LD, Lougaris V, Plebani A: Mutational analysis of human BAFF receptor TNFRSF13C (BAFFR) in patients with common variable immunodeficiency. J Clin Immunol 2005; 25: 496-502.
141. Ng LG, Sutherland AP, Newton R, Qian F, Cachero TG, Scott ML, Thompson JS, Wheway J, Chtanova T, Groom J, Sutton IJ, Xin C, Tangye SG, Kalled SL, Mackay F, Mackay CR: B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J Immunol 2004; 173: 807-817.
142. Castigli E, Wilson SA, Scott S, Dedeoglu F, Xu S, Lam KP, Bram RJ, Jabara H, Geha RS: TACI and BAFF-R mediate isotype switching in B cells. J Exp Med 2005; 201: 35-39.
143. Warnatz K, Salzer U, Gutenberger S, Schlesier M, Grimbacher B, Peter HH, Eibel H: Finally found: human BAFF-R deficiency causes hypogammaglobulinemia. Clin Immunol 2005; 115:S20.
144. Sekine H, Ferreira RC, Pan-Hammarstrom Q, Graham RR, Ziemba B, de Vries SS, Liu J, Hippen K, Koeuth T, Ortmann W, Iwahori A, Elliott MK, Offer S, Skon C, Du L, Novitzke J, Lee AT, Zhao N, Tompkins JD, Altshuler D, Gregersen PK, Cunningham-Rundles C, Harris RS, Her C, Nelson DL, Hammarstrom L, Gilkeson GS, Behrens TW: Role for Msh5 in the regulation of Ig class switch recombination. Proc Natl Acad Sci USA 2007; 104: 7193-7198. (Pubitemid 47186031)
145. Wu X, Tsai CY, Patam MB, Zan H, Chen JP, Lipkin SM, Casali P: A role for the MutL mismatch repair Mlh3 protein in immunoglobulin class switch DNA recombination and somatic hypermutation. J Immunol 2006; 176: 5426-5437.
146. Bruton OC: Agammaglobulinemia. Pediatrics 1952; 9: 722-728.
147. Berger M: Principles of and advances in immunoglobulin replacement therapy for primary immunodeficiency. Immunol Allergy Clin North Am 2008; 28: 413-437.
148. Busse PJ, Razvi S, Cunningham-Rundles C: Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol 2002; 109: 1001-1004.
149. Garcia-Lloret M, McGhee S, Chatila TA: Immunoglobulin replacement therapy in children. Immunol Allergy Clin North Am 2008; 28: 833-849.
150. Berger M: Subcutaneous immunoglobulin replacement in primary immunodeficiencies. Clin Immunol 2004; 112: 1-7.
151. Berger M, Cupps TR, Fauci AS: Immunoglobulin replacement therapy by slow subcutaneous infusion. Ann Intern Med 1980; 93: 55-56.
152. Moore ML, Quinn JM: Subcutaneous immunoglobulin replacement therapy for primary antibody deficiency: advancements into the 21st century. Ann Allergy Asthma Immunol 2008; 101: 114-121; quiz 122-113, 178.
153. Gardulf A, Borte M, Ochs HD, Nicolay U: Prognostic factors for health-related quality of life in adults and children with primary antibody deficiencies receiving SCIG home therapy. Clin Immunol 2008; 126: 81-88.
154. Gardulf A, Nicolay U: Replacement IgG therapy and self-therapy at home improve the health-related quality of life in patients with primary antibody deficiencies. Curr Opin Allergy Clin Immunol 2006; 6: 434-442.
155. Gardulf A, Nicolay U, Math D, Asensio O, Bernatowska E, Bock A, Costa-Carvalho BT, Granert C, Haag S, Hernandez D, Kiessling P, Kus J, Matamoros N, Niehues T, Schmidt S, Schulze I, Borte M: Children and adults with primary
156. Orange JS, Hossny EM, Weiler CR, Ballow M, Berger M, Bonilla FA, Buckley R, Chinen J, El-Gamal Y, Mazer BD, Nelson RP Jr., Patel DD, Secord E, Sorensen RU, Wasserman RL, Cunningham-Rundles C: Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol 2006; 117:S525-S553.
157. Gelfand EW, Goldsmith J, Lederman HM: Primary humoral immunodeficiency: optimizing IgG replacement therapy. Clin Focus Prim Immune Defic 2003; 11: 1-15.
158. Burks AW, Sampson HA, Buckley RH: Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia: detection of IgE antibodies to IgA. N Engl J Med 1986; 314: 560-564.
159. Cunningham-Rundles C, Wong S, Bjorkander J, Hanson LA: Use of an IgA-depleted intravenous immunoglobulin in a patient with an anti-IgA antibody. Clin Immunol Immunopathol 1986; 38: 141-149.
160. Cunningham-Rundles C, Zhou Z, Mankarious S, Courter S: Long-term use of IgAdepleted intravenous immunoglobulin in immunodeficient subjects with anti-IgA antibodies. J Clin Immunol 1993; 13: 272-278.
161. Orange J: The nuts and bolts of immunoglobulin administration. Am Coll Allergy, Asthma Immunol Sci Meet, Seattle, 2008, pp 405-412.
162. Bates CA, Brown K, Routes J: Pulmonary disease associated with common variable immunodeficiency. J Allergy Clin Immunol 2002; 109:S188.
163. FDA public health notification: reducing radiation risk from computed tomography for pediatric and small adult patients. Pediatr Radiol 2002; 32: 314-316.
164. Brenner D, Elliston C, Hall E, Berdon W: Estimated risks of radiation-induced fatal cancer from pediatric CT. AJR Am J Roentgenol 2001; 176: 289-296.
165. Brenner DJ, Hall EJ: Computed tomography: an increasing source of radiation exposure. N Engl J Med 2007; 357: 2277-2284.
166. Vorechovsky I, Scott D, Haeney MR, Webster DA: Chromosomal radiosensitivity in common variable immune deficiency. Mutat Res 1993; 290: 255-264.
167. Yong PFK, Tarzi M, Chua I, Grimbacher B, Chee R: Common variable immunodeficiency: an update on etiology and management. Immunol Allergy Clin North Am 2008; 28: 367-386.
168. Guzman D, Veit D, Knerr V, Kindle G, Gathmann B, Eades-Perner AM, Grimbacher B: The ESID Online Database network. Bioinformatics 2007; 23: 654-655.
169. Keerthikumar S, Raju R, Kandasamy K, Hijikata A, Ramabadran S, Balakrishnan L, Ahmed M, Rani S, Selvan LD, Somanathan DS, Ray S, Bhattacharjee M, Gollapudi S, Ramachandra YL, Bhadra S, Bhattacharyya C, Imai K, Nonoyama S, Kanegane H, Miyawaki T, Pandey A, Ohara O, Mohan S: RAPID: Resource of Asian Primary Immunodeficiency Diseases. Nucleic Acids Res 2008; 37:D863-D867.
170. Ochs H, Cunningham Rundles C: US Immunodeficiency Network. www.usidnet. org/index.cfm.
171. Allen RC, Armitage RJ, Conley ME, et al: CD40 ligand gene defects responsible for Xlinked hyper-IgM syndrome. Science 1993; 259: 990-993.
172. Aruffo A, Farrington M, Hollenbaugh D, et al: The CD40 ligand, gp39, is defective in activated T cells from patients with Xlinked hyper-IgM syndrome. Cell 1993; 72: 291-300.
173. DiSanto JP, Bonnefoy JY, Gauchat JF, Fischer A, de Saint Basile G: CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM. Nature 1993; 361: 541-543.
174. Farrington M, Grosmaire LS, Nonoyama S, Fischer SH, Hollenbaugh D, Ledbetter JA, Noelle RJ, Aruffo A, Ochs HD: CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc Natl Acad Sci USA 1994; 91: 1099-1103.
175. Korthauer U, Graf D, Mages HW, Briere F, Padayachee M, Malcolm S, Ugazio AG, Notarangelo LD, Levinsky RJ, Kroczek RA: Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 1993; 361: 539-541.
176. Minegishi Y, Lavoie A, Cunningham-Rundles C, Bedard PM, Hebert J, Cote L, Dan K, Sedlak D, Buckley RH, Fischer A, Durandy A, Conley ME: Mutations in activation- induced cytidine deaminase in patients with hyper IgM syndrome. Clin Immunol 2000; 97: 203-210.
177. Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, Catalan N, Forveille M, Dufourcq-Labelouse R, Gennery A, Tezcan I, Ersoy F, Kayserili H, Ugazio AG, Brousse N, Muramatsu M, Notarangelo LD, Kinoshita K, Honjo T, Fischer A, Durandy A: Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 2000; 102: 565-575.
178. Ferrari S, Giliani S, Insalaco A, Al-Ghonaium A, Soresina AR, Loubser M, Avanzini MA, Marconi M, Badolato R, Ugazio AG, Levy Y, Catalan N, Durandy A, Tbakhi A, Notarangelo LD, Plebani A: Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci USA 2001; 98: 12614-12619.
179. Imai K, Catalan N, Plebani A, Marodi L, Sanal O, Kumaki S, Nagendran V, Wood P, Glastre C, Sarrot-Reynauld F, Hermine O, Forveille M, Revy P, Fischer A, Durandy A: Hyper-IgM syndrome type 4 with a B lymphocyte- intrinsic selective deficiency in Ig class-switch recombination. J Clin Invest 2003; 112: 136-142.
180. Imai K, Slupphaug G, Lee WI, Revy P, Nonoyama S, Catalan N, Yel L, Forveille M, Kavli B, Krokan HE, Ochs HD, Fischer A, Durandy A: Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat Immunol 2003; 4: 1023-1028.
181. Jain A, Ma CA, Liu S, Brown M, Cohen J, Strober W: Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol 2001; 2: 223-228.
182. Saffran DC, Parolini O, Fitch-Hilgenberg ME, Rawlings DJ, Afar DE, Witte ON, Conley ME: Brief report: a point mutation in the SH2 domain of Bruton's tyrosine kinase in atypical X-linked agammaglobulinemia. N Engl J Med 1994; 330: 1488-1491.
183. Tsukada S, Saffran DC, Rawlings DJ, et al: Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 1993; 72: 279-290.
184. Vetrie D, Vorechovsky I, Sideras P, et al: The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 1993; 361: 226-233.
185. Coffey AJ, Brooksbank RA, Brandau O, Oohashi T, Howell GR, Bye JM, Cahn AP, Durham J, Heath P, Wray P, Pavitt R, Wilkinson J, Leversha M, Huckle E, Shaw- Smith CJ, Dunham A, Rhodes S, Schuster V, Porta G, Yin L, Serafini P, Sylla B, Zollo M, Franco B, Bolino A, Seri M, Lanyi A, Davis JR, Webster D, Harris A, Lenoir G, de St Basile G, Jones A, Behloradsky BH, Achatz H, Murken J, Fassler R, Sumegi J, Romeo G, Vaudin M, Ross MT, Meindl A, Bentley DR: Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet 1998; 20: 129-135.
186. Rigaud S, Fondaneche MC, Lambert N, Pasquier B, Mateo V, Soulas P, Galicier L, Le Deist F, Rieux-Laucat F, Revy P, Fischer A, de Saint Basile G, Latour S: XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 2006; 444: 110-114.
187. Sayos J, Wu C, Morra M, Wang N, Zhang X, Allen D, van Schaik S, Notarangelo L, Geha R, Roncarolo MG, Oettgen H, De Vries JE, Aversa G, Terhorst C: The X-linked lymphoproliferative- disease gene product SAP regulates signals induced through the coreceptor SLAM. Nature 1998; 395: 462-469.
188. Zhang R, Szerlip HM: Reemergence of sucrose nephropathy: acute renal failure caused by high-dose intravenous immune globulin therapy. South Med J 2000; 93: 901-904.
189. Sewell WA, Buckland M, Jolles SR: Therapeutic strategies in common variable immunodeficiency. Drugs 2003; 63: 1359-1371.